𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors

✍ Scribed by Elliot J. Mitmaker; Nicholas J. Griff; Raymon H. Grogan; Rajabrata Sarkar; Electron Kebebew; Quan-Yang Duh; Orlo H. Clark; Wen T. Shen

Book ID
113921671
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
225 KB
Volume
149
Category
Article
ISSN
0039-6060

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel inhibitors of urokinase-type plasm
Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines
✍ Kristina Cakarovski; Jenny Y. Leung; Christina Restall; Anna Carin-Carlson; Euni πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 339 KB πŸ‘ 1 views

## Abstract The plasminogen‐activating (PA) and matrix metalloproteinase (MMP) enzyme systems are implicated in proteolytic turnover of the extracellular matrix (ECM) associated with biologic processes including wound healing, inflammation and angiogenesis. Aberrant expression of components of the

The use of histone deacetylase inhibitor
The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy
✍ Jose A. Karam; Jinhai Fan; Jennifer Stanfield; Edmond Richer; Elie A. Benaim; Eu πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 811 KB

## Abstract The long‐term disease‐free survival in patients with metastatic transitional cell carcinoma (TCC) is still considerably low. Novel chemotherapeutic agents are needed to decrease the morbidity and mortality of TCC. In this study, we have evaluated several epigenetic modifiers for their t